Figure 1.
Cumulative incidence of new-onset diabetes in the dalcetrapib and placebo groups among all patients without diabetes at baseline (A) and among patients with prediabetes at baseline (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.